https://www.marketscreener.com/quote/stock/CORMEDIX-INC-56358385/news/CorMedix-Inc-Announces-U-S-Inpatient-Commercial-Availability-of-DefenCath-Taurolidine-and-Hepar-46435364/?utm_source=telegram&utm_medium=social&utm_campaign=share